Prevention of the foreign body response to implantable medical devices by inflammasome inhibition

Author:

Barone Damiano G.1234ORCID,Carnicer-Lombarte Alejandro145,Tourlomousis Panagiotis3,Hamilton Russell S.67ORCID,Prater Malwina67ORCID,Rutz Alexandra L.4,Dimov Ivan B.45,Malliaras George G.4ORCID,Lacour Stephanie P.8ORCID,Robertson Avril A. B.9ORCID,Franze Kristian51011ORCID,Fawcett James W.112,Bryant Clare E.313ORCID

Affiliation:

1. John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0PY, United Kingdom

2. Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0PY, United Kingdom

3. Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, United Kingdom

4. Electrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge CB3 0FA, United Kingdom

5. Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3DY, United Kingdom

6. Centre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, United Kingdom

7. Department of Genetics, University of Cambridge, Cambridge CB2 3EH, United Kingdom

8. Bertarelli Foundation Chair in Neuroprosthetic Technology, Laboratory for Soft Bioelectronics Interface, Institute of Microengineering, Institute of Bioengineering, Centre for Neuroprosthetics, Ecole Polytechnique Fédérale de Lausanne, 1202 Geneva, Switzerland

9. School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia

10. Max-Planck-Zentrum für Physik und Medizin, 91054 Erlangen, Germany

11. Institute of Medical Physics and Microtissue Engineering, Friedrich-Alexander University Erlangen–Nuremberg, 91052 Erlangen, Germany

12. Centre for Reconstructive Neuroscience, Institute for Experimental Medicine, Czech Academy of Sciences, 142 20 Prague 4, Czech Republic

13. Division of Medicine, University of Cambridge, Cambridge CB2 0PY, United Kingdom

Abstract

SignificanceImplantable electronic medical devices (IEMDs) are used for some clinical applications, representing an exciting prospect for the transformative treatment of intractable conditions such Parkinson’s disease, deafness, and paralysis. The use of IEMDs is limited at the moment because, over time, a foreign body reaction (FBR) develops at the device–neural interface such that ultimately the IEMD fails and needs to be removed. Here, we show that macrophage nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activity drives the FBR in a nerve injury model yet integration of an NLRP3 inhibitor into the device prevents FBR while allowing full healing of damaged neural tissue to occur.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3